Abstract 4369077: Postoperative Inflammation Promotes HDL Dysfunction, Disrupting Reverse Cholesterol Transport and Driving Rapid Atherosclerotic Plaque Destabilization

D Dominique Boucher (University of Ottawa Heart Institute, Ottawa, Ontario, Canada) V Valérie Rochon (University of Ottawa Heart Institute, Ottawa, Ontario, Canada) T Thomas Laval (University of Ottawa Heart Institute, Ottawa, Ontario, Canada) V Victoria Lorant (University of Ottawa Heart Institute, Ottawa, Ontario, Canada) A Abigail Carter (University of Kentucky, Lancaster, Kentucky, United States) C Chrissy Emerton (University of Ottawa Heart Institute, Ottawa, Ontario, Canada) N Nathan Joyce (University of Ottawa Heart Institute, Ottawa, Ontario, Canada) N Nysa Vinayak (University of Ottawa Heart Institute, Ottawa, Ontario, Canada) M Marlena Scaffidi (Ottawa Hospital Research Institute, Ottawa, Ontario, Canada) R Rebecca Auer (Ottawa Hospital Research Institute, Ottawa, Ontario, Canada) S Scott Gordon (University of Kentucky, Lexington, Kentucky, United States) M Mireille Ouimet (University of Ottawa Heart Institute, Ottawa, Ontario, Canada)

Abstract

Background: Myocardial Injury after Noncardiac Surgery (MINS) affects ∼1 in 6 patients undergoing major noncardiac procedures. A subset of MINS cases is linked to atherosclerotic plaque disruption, but the mechanisms driving this postoperative instability remain poorly defined. Reverse Cholesterol Transport (RCT), the removal of peripheral cholesterol by HDL and apoA-I, is critical for limiting plaque progression. Surgical inflammation is known to impair HDL function, but its impact on RCT and plaque stability is poorly understood. Hypothesis: Postoperative inflammatory remodeling of the HDL proteome impairs RCT, promoting cholesterol accumulation and necrotic core expansion in atherosclerotic plaques. Results: ApoE -/- mice on a Western diet underwent exploratory laparotomy or anesthesia only (control). LC-MS/MS of HPLC-isolated HDL revealed extensive postoperative inflammatory remodeling, marked by elevated serum amyloid A (SAA) and reduced apoA-I, impairing multiple RCT-related pathways as identified by Gene Ontology analysis. In vitro, macrophage (MΦ) cholesterol efflux to postoperative plasma and HDL was substantially reduced, while vascular smooth muscle cell (VSMC) efflux showed modest reductions. Using a novel dual-label, dual-cell-type in vivo RCT assay—subcutaneously injecting 3 H-cholesterol-labeled MΦs and 14 C-cholesterol-labeled VSMCs—MΦ RCT was significantly impaired for >48h post-op, whereas VSMC RCT was largely preserved. In human noncardiac surgery patients (n=21), in vitro MΦ cholesterol efflux to postoperative plasma was similarly impaired. In plaques, lipid accumulation (BODIPY) and perilipin-2 (PLIN2) expression increased in both MΦs and VSMCs at 24h after surgery. Apoptotic (cleaved caspase-3 + ) cells were enriched postoperatively, predominantly among PLIN2 high populations. Neutrophil extracellular traps (H3Cit + MPO + ) and inflammatory MΦs (TREM1 + ) were also elevated. By 72h and 15d postop, plaques exhibited reduced cellularity, fewer lipid-rich cells, and increased necrotic core area, suggesting acute lipid loading contributed to cell death and destabilization. Notably, rApoA-I treatment partially restored RCT and reduced plaque lipid accumulation. Conclusion: Postoperative inflammation disrupts RCT, driving lipid accumulation, cell death, and plaque destabilization. These findings reveal remarkably rapid, inflammation-driven changes in plaque lipid handling after surgery and suggest potential for targeted postoperative interventions.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (12)

D

Dominique Boucher

University of Ottawa Heart Institute, Ottawa, Ontario, Canada

V

Valérie Rochon

University of Ottawa Heart Institute, Ottawa, Ontario, Canada

T

Thomas Laval

University of Ottawa Heart Institute, Ottawa, Ontario, Canada

V

Victoria Lorant

University of Ottawa Heart Institute, Ottawa, Ontario, Canada

A

Abigail Carter

University of Kentucky, Lancaster, Kentucky, United States

C

Chrissy Emerton

University of Ottawa Heart Institute, Ottawa, Ontario, Canada

N

Nathan Joyce

University of Ottawa Heart Institute, Ottawa, Ontario, Canada

N

Nysa Vinayak

University of Ottawa Heart Institute, Ottawa, Ontario, Canada

M

Marlena Scaffidi

Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

R

Rebecca Auer

Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

S

Scott Gordon

University of Kentucky, Lexington, Kentucky, United States

M

Mireille Ouimet

University of Ottawa Heart Institute, Ottawa, Ontario, Canada